United States Biotechnology & Medical Research

Immunic Inc (IMUX)

Track

Recent insider activity at Immunic Inc. shows a series of buy transactions by executives and other insiders, with the most recent occurring on June 13, 2025. These purchases, totaling over $270,000 across multiple individuals, indicate continued confidence from key personnel. The last reported insider transaction prior to this was on November 12, 2024.
Stock chart
Ticker: IMUX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Nash Duane
Executive Chairman
1 purchase — total 16,694 USD
Buy 13 Jun 2025
Value US$4,872,956.46 | Price 177.07 | Shares 68,710
Buy 5 Jun 2025
Value US$3,106,697.08 | Price 18.17 | Shares 39,982
Buy 5 Jun 2025
Value US$22,800.00 | Price 0.76 | Shares 30,000
Buy 4 Jun 2025
Value US$11,550.00 | Price 0.77 | Shares 15,000
Buy 4 Jun 2025
Value US$53,900.00 | Price 0.77 | Shares 70,000
Buy 3 Jun 2025
Value US$32,076.00 | Price 0.71 | Shares 45,000
Buy 3 Jun 2025
Value US$100,023.73 | Price 0.70 | Shares 143,075
Buy 12 Nov 2024
Value US$100,368.81 | Price 1.15 | Shares 87,300
Buy 26 Feb 2024
Value US$18,333.00 | Price 1.31 | Shares 14,000
Planned buy 15 May 2023
Value US$8,750.00 | Price 1.75 | Shares 5,000
Buy 14 Dec 2022
Value US$59,032.00 | Price 1.26 | Shares 47,000
Buy 13 Dec 2022
Value US$43,610.00 | Price 1.25 | Shares 35,000
Buy 23 Nov 2022
Value US$25,020.00 | Price 1.39 | Shares 18,000
Buy 22 Nov 2022
Value US$10,799.20 | Price 1.35 | Shares 8,000
Planned buy 7 Nov 2022
Value US$7,475.00 | Price 1.50 | Shares 5,000
Buy 3 Jun 2022
Value US$15,499.50 | Price 3.10 | Shares 5,000
Buy 3 Jun 2022
Value US$10,657.50 | Price 3.05 | Shares 3,500
Buy 12 May 2022
Value US$17,850.00 | Price 5.10 | Shares 3,500
Buy 12 May 2022
Value US$15,240.00 | Price 5.08 | Shares 3,000
Buy 12 May 2022
Value US$50,300.00 | Price 5.03 | Shares 10,000
Buy 10 Aug 2021
Value US$9,800.00 | Price 9.80 | Shares 1,000
Buy 2 Mar 2021
Value US$155,493.24 | Price 15.54 | Shares 10,006
Buy 2 Mar 2021
Value US$16,480.00 | Price 16.48 | Shares 1,000
Buy 10 Aug 2020
Value US$18,960.00 | Price 18.96 | Shares 1,000
Planned sale 21 Jul 2020
Value US$10,154.88 | Price 15.62 | Shares 650
Planned sale 21 Jul 2020
Value US$20,309.77 | Price 15.62 | Shares 1,300
Planned sale 20 Jul 2020
Value US$72,200.50 | Price 14.44 | Shares 5,000
Planned sale 20 Jul 2020
Value US$72,200.50 | Price 14.44 | Shares 5,000
Planned sale 4 Dec 2019
Value US$30,624.00 | Price 6.96 | Shares 4,400
Sale 25 Sep 2018
Value US$2,900.00 | Price 0.29 | Shares 10,000
Sale 25 Sep 2018
Value US$25,939.87 | Price 0.29 | Shares 89,417
Sale 24 Sep 2018
Value US$8,001.67 | Price 0.30 | Shares 26,619
Sale 19 Sep 2018
Value US$24,191.06 | Price 0.35 | Shares 69,375
Sale 17 Sep 2018
Value US$2,054,256.97 | Price 0.29 | Shares 7,044,777
Sale 14 Sep 2018
Value US$160,384.00 | Price 0.36 | Shares 447,500
Sale 13 Sep 2018
Value US$9,400.00 | Price 0.47 | Shares 20,000
Sale 13 Sep 2018
Value US$1,930,996.00 | Price 0.50 | Shares 3,890,000
Sale 13 Sep 2018
Value US$51,766.79 | Price 0.44 | Shares 118,243
Sale 13 Sep 2018
Value US$25,911.84 | Price 0.44 | Shares 59,200
Sale 12 Sep 2018
Value US$1,925.00 | Price 0.55 | Shares 3,500
Buy 13 Dec 2017
Value US$278,570.00 | Price 5.57 | Shares 50,000
Buy 12 Dec 2017
Value US$269,765.00 | Price 5.40 | Shares 50,000
Buy 11 Dec 2017
Value US$248,225.00 | Price 4.96 | Shares 50,000
Buy 8 Dec 2017
Value US$246,185.00 | Price 4.92 | Shares 50,000
Buy 7 Dec 2017
Value US$238,730.00 | Price 4.77 | Shares 50,000
Buy 14 Sep 2017
Value US$247,870.40 | Price 4.19 | Shares 59,200
Buy 14 Sep 2017
Value US$127,539.00 | Price 4.25 | Shares 30,000
Buy 13 Sep 2017
Value US$39,969.00 | Price 4.00 | Shares 10,000
Buy 13 Sep 2017
Value US$206,465.00 | Price 4.13 | Shares 50,000
Buy 12 Sep 2017
Value US$187,225.00 | Price 3.74 | Shares 50,000
Buy 8 Sep 2017
Value US$176,615.00 | Price 3.53 | Shares 50,000
Buy 14 Jun 2017
Value US$7,416.96 | Price 3.09 | Shares 2,400
Buy 14 Jun 2017
Value US$307.50 | Price 3.08 | Shares 100
Buy 14 Jun 2017
Value US$30,981.00 | Price 3.10 | Shares 10,000
Buy 14 Jun 2017
Value US$31,008.00 | Price 3.10 | Shares 10,000
Buy 13 Jun 2017
Value US$48,068.80 | Price 3.00 | Shares 16,000
Buy 13 Jun 2017
Value US$30,311.00 | Price 3.03 | Shares 10,000
Buy 12 Jun 2017
Value US$30,615.00 | Price 3.06 | Shares 10,000
Buy 9 Jun 2017
Value US$6,360.00 | Price 3.18 | Shares 2,000
Buy 9 Jun 2017
Value US$31,733.00 | Price 3.17 | Shares 10,000
Buy 8 Jun 2017
Value US$30,958.00 | Price 3.10 | Shares 10,000
Buy 8 Jun 2017
Value US$12,182.04 | Price 3.12 | Shares 3,900
Buy 7 Jun 2017
Value US$32,074.00 | Price 3.21 | Shares 10,000
Buy 6 Jun 2017
Value US$31,940.00 | Price 3.19 | Shares 10,000
Buy 27 Mar 2017
Value US$15,000,000.00 | Price 4.00 | Shares 3,750,000
Buy 12 Aug 2016
Value US$699,998.56 | Price 5.92 | Shares 118,243
Buy 28 Oct 2015
Value US$2,200,000.00 | Price 5.50 | Shares 400,000
Buy 26 Oct 2015
Value US$14,000.00 | Price 7.00 | Shares 2,000
Buy 26 Oct 2015
Value US$25,089.75 | Price 7.17 | Shares 3,500
Buy 23 Oct 2015
Value US$49,932.94 | Price 6.76 | Shares 7,385
Buy 10 Sep 2015
Value US$18,293.40 | Price 3.05 | Shares 6,000
Buy 9 Sep 2015
Value US$6,320.00 | Price 3.16 | Shares 2,000
Buy 9 Sep 2015
Value US$6,200.00 | Price 3.10 | Shares 2,000
Buy 9 Sep 2015
Value US$12,280.00 | Price 3.07 | Shares 4,000
Buy 10 Oct 2014
Value US$10,132.00 | Price 14.90 | Shares 680
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-16 2025-06-13 B Purchase
2.4
Nash Duane

Executive Chairman

Executive Director
68,710 -25.5%
177.07
US$4,872,956 		68,710 -25.5% 177.07 US$4,872,956
2025-06-09 2025-06-05 B Purchase
2.2
Tardio Jason

President and COO

Officer
39,982 +33.6%
18.17
US$3,106,697 		39,982 +33.6% 18.17 US$3,106,697
2025-06-05 2025-06-05 B Purchase
3.7
Neermann Joerg
Non-Executive Director
4,776 +26.7%
42.24
US$1,334,680 		4,776 +26.7% 42.24 US$1,334,680
2025-06-06 2025-06-04 B Purchase
3.2
Vitt Daniel

CEO and Director

Executive Director
15,000 +107.1%
0.77
US$11,550 		15,000 +107.1% 0.77 US$11,550
2025-06-05 2025-06-04 B Purchase
3.7
Neermann Joerg
Non-Executive Director
70,000 +70.0%
0.77
US$53,900 		70,000 +70.0% 0.77 US$53,900
2025-06-04 2025-06-03 B Purchase
3.0
Whaley Glenn

Chief Financial Officer

Officer
45,000 +89.1%
0.71
US$32,076 		45,000 +89.1% 0.71 US$32,076
2025-06-04 2025-06-03 B Purchase
2.8
Rudick Richard Alan
Non-Executive Director
143,075 +163.9%
0.70
US$100,024 		143,075 +163.9% 0.70 US$100,024
2024-11-13 2024-11-12 B Purchase
2.8
Rudick Richard Alan
Non-Executive Director
87,300 +inf%
1.15
US$100,369 		87,300 +inf% 1.15 US$100,369
2024-02-28 2024-02-26 B Purchase
3.2
Vitt Daniel

President and CEO

Executive Director
14,000 +3.7%
1.31
US$18,333 		14,000 +3.7% 1.31 US$18,333
2023-05-16 2023-05-15 PP Planned purchase
3.0
Whaley Glenn

Chief Financial Officer

Officer
5,000 +24.4%
1.75
US$8,750 		5,000 +24.4% 1.75 US$8,750
2022-12-15 2022-12-14 B Purchase
3.7
Neermann Joerg
Non-Executive Director
47,000 +88.7%
1.26
US$59,032 		47,000 +88.7% 1.26 US$59,032
2022-12-15 2022-12-13 B Purchase
3.7
Neermann Joerg
Non-Executive Director
35,000 +194.4%
1.25
US$43,610 		35,000 +194.4% 1.25 US$43,610
2022-11-25 2022-11-23 B Purchase
3.7
Neermann Joerg
Non-Executive Director
18,000 +inf%
1.39
US$25,020 		18,000 +inf% 1.39 US$25,020
2022-11-23 2022-11-22 B Purchase
3.2
Vitt Daniel

President and CEO

Executive Director
8,000 +2.2%
1.35
US$10,799 		8,000 +2.2% 1.35 US$10,799
2022-11-08 2022-11-07 PP Planned purchase
3.0
Whaley Glenn

Chief Financial Officer

Officer
5,000 +32.2%
1.50
US$7,475 		5,000 +32.2% 1.50 US$7,475
2022-06-06 2022-06-03 B Purchase
3.2
Vitt Daniel

President and CEO

Executive Director
5,000 +1.4%
3.10
US$15,500 		5,000 +1.4% 3.10 US$15,500
2022-06-06 2022-06-03 B Purchase
3.0
Whaley Glenn

Chief Financial Officer

Officer
3,500 +38.6%
3.05
US$10,658 		3,500 +38.6% 3.05 US$10,658
2022-05-16 2022-05-12 B Purchase
1.9
Muehler Andreas

Chief Medical Officer

Officer
3,500 +1.2%
5.10
US$17,850 		3,500 +1.2% 5.10 US$17,850
2022-05-13 2022-05-12 B Purchase
3.0
Whaley Glenn

Chief Financial Officer

Officer
3,000 +49.4%
5.08
US$15,240 		3,000 +49.4% 5.08 US$15,240
2022-05-13 2022-05-12 B Purchase
2.4
Nash Duane

Executive Chairman

Executive Director
10,000 +83.1%
5.03
US$50,300 		10,000 +83.1% 5.03 US$50,300
2021-08-11 2021-08-10 B Purchase
2.4
Nash Duane

Executive Chairman

Executive Director
1,000 +7.1%
9.80
US$9,800 		1,000 +7.1% 9.80 US$9,800
2021-03-15 2021-03-02 B Purchase
1.9
Muehler Andreas

Chief Medical Officer

Officer
10,006 +3.5%
15.54
US$155,493 		10,006 +3.5% 15.54 US$155,493
2021-03-03 2021-03-02 B Purchase
3.0
Whaley Glenn

PFO and PAO

Officer
1,000 +100.0%
16.48
US$16,480 		1,000 +100.0% 16.48 US$16,480
2020-08-10 2020-08-10 B Purchase
3.0
Whaley Glenn

PFO and PAO

Officer
1,000 +inf%
18.96
US$18,960 		1,000 +inf% 18.96 US$18,960
2020-07-22 2020-07-21 PlS Planned sale
Groeppel Manfred

Chief Operating Officer

Officer
650 -0.2%
15.62
US$10,155 		650 -0.2% 15.62 US$10,155
2020-07-22 2020-07-21 PlS Planned sale
3.2
Vitt Daniel

Chief Executive Officer

Executive Director
1,300 -0.4%
15.62
US$20,310 		1,300 -0.4% 15.62 US$20,310
2020-07-22 2020-07-20 PlS Planned sale
3.2
Vitt Daniel

Chief Executive Officer

Executive Director
5,000 -1.4%
14.44
US$72,200 		5,000 -1.4% 14.44 US$72,200
2020-07-22 2020-07-20 PlS Planned sale
Groeppel Manfred

Chief Operating Officer

Officer
5,000 -1.8%
14.44
US$72,200 		5,000 -1.8% 14.44 US$72,200
2019-12-04 2019-12-04 PlS Planned sale Nash Duane Non-Executive Director
4,400 -30.5%
6.96
US$30,624 		4,400 -30.5% 6.96 US$30,624
2018-09-25 2018-09-25 S Sale Halperin Errol R. Non-Executive Director
10,000 -100.0%
0.29
US$2,900 		10,000 -100.0% 0.29 US$2,900
2018-09-25 2018-09-25 S Sale Halperin Errol R. Non-Executive Director
89,417 -100.0%
0.29
US$25,940 		89,417 -100.0% 0.29 US$25,940
2018-09-24 2018-09-24 S Sale
2.4
BIENAIME JEAN JACQUES
Non-Executive Director
26,619 -59.0%
0.30
US$8,002 		26,619 -59.0% 0.30 US$8,002
2018-09-21 2018-09-19 S Sale Godshall Douglas Evan Non-Executive Director
69,375 -100.0%
0.35
US$24,191 		69,375 -100.0% 0.35 US$24,191
2018-09-17 2018-09-17 S Sale Satter Muneer A Non-Executive Director Large shareholder
7,044,777 -100.0%
0.29
US$2,054,257 		7,044,777 -100.0% 0.29 US$2,054,257
2018-09-17 2018-09-14 S Sale Satter Muneer A Non-Executive Director Large shareholder
447,500 -6.0%
0.36
US$160,384 		447,500 -6.0% 0.36 US$160,384
2018-09-17 2018-09-13 S Sale
2.4
BIENAIME JEAN JACQUES
Non-Executive Director
20,000 -30.7%
0.47
US$9,400 		20,000 -30.7% 0.47 US$9,400
2018-09-17 2018-09-13 S Sale Satter Muneer A Non-Executive Director Large shareholder
3,890,000 -34.2%
0.50
US$1,930,996 		3,890,000 -34.2% 0.50 US$1,930,996
2018-09-17 2018-09-13 S Sale
2.7
Hasnain Faheem
Non-Executive Director
118,243 -96.3%
0.44
US$51,767 		118,243 -96.3% 0.44 US$51,767
2018-09-17 2018-09-13 S Sale
2.7
Hasnain Faheem
Non-Executive Director
59,200 -32.5%
0.44
US$25,912 		59,200 -32.5% 0.44 US$25,912
2018-09-14 2018-09-12 S Sale
3.2
Cohen Cheryl
Non-Executive Director
3,500 -100.0%
0.55
US$1,925 		3,500 -100.0% 0.55 US$1,925
2017-12-14 2017-12-13 B Purchase Satter Muneer A Large shareholder
50,000 +0.4%
5.57
US$278,570 		50,000 +0.4% 5.57 US$278,570
2017-12-14 2017-12-12 B Purchase Satter Muneer A Large shareholder
50,000 +0.4%
5.40
US$269,765 		50,000 +0.4% 5.40 US$269,765
2017-12-11 2017-12-11 B Purchase Satter Muneer A Large shareholder
50,000 +0.4%
4.96
US$248,225 		50,000 +0.4% 4.96 US$248,225
2017-12-11 2017-12-08 B Purchase Satter Muneer A Large shareholder
50,000 +0.4%
4.92
US$246,185 		50,000 +0.4% 4.92 US$246,185
2017-12-11 2017-12-07 B Purchase Satter Muneer A Large shareholder
50,000 +0.4%
4.77
US$238,730 		50,000 +0.4% 4.77 US$238,730
2017-09-15 2017-09-14 B Purchase
2.7
Hasnain Faheem
59,200 +48.2%
4.19
US$247,870 		59,200 +48.2% 4.19 US$247,870
2017-09-14 2017-09-14 B Purchase Satter Muneer A Large shareholder
30,000 +0.3%
4.25
US$127,539 		30,000 +0.3% 4.25 US$127,539
2017-09-14 2017-09-13 B Purchase
2.4
BIENAIME JEAN JACQUES
10,000 +18.1%
4.00
US$39,969 		10,000 +18.1% 4.00 US$39,969
2017-09-14 2017-09-13 B Purchase Satter Muneer A Large shareholder
50,000 +0.5%
4.13
US$206,465 		50,000 +0.5% 4.13 US$206,465
2017-09-14 2017-09-12 B Purchase Satter Muneer A Large shareholder
50,000 +0.5%
3.74
US$187,225 		50,000 +0.5% 3.74 US$187,225
2017-09-12 2017-09-08 B Purchase Satter Muneer A Large shareholder
50,000 +0.5%
3.53
US$176,615 		50,000 +0.5% 3.53 US$176,615
2017-06-15 2017-06-14 B Purchase DUNN JOHN MICHAEL

General Counsel and Secretary
2,400 +25.3%
3.09
US$7,417 		2,400 +25.3% 3.09 US$7,417
2017-06-15 2017-06-14 B Purchase DUNN JOHN MICHAEL

General Counsel and Secretary
100 +1.1%
3.08
US$308 		100 +1.1% 3.08 US$308
2017-06-15 2017-06-14 B Purchase Winters Terence E.

Co-Chairman and CEO

Executive Director
10,000 +5.4%
3.10
US$30,981 		10,000 +5.4% 3.10 US$30,981
2017-06-14 2017-06-14 B Purchase Satter Muneer A Large shareholder
10,000 +0.1%
3.10
US$31,008 		10,000 +0.1% 3.10 US$31,008
2017-06-15 2017-06-13 B Purchase
2.4
BIENAIME JEAN JACQUES
16,000 +40.9%
3.00
US$48,069 		16,000 +40.9% 3.00 US$48,069
2017-06-14 2017-06-13 B Purchase Satter Muneer A Large shareholder
10,000 +0.1%
3.03
US$30,311 		10,000 +0.1% 3.03 US$30,311
2017-06-12 2017-06-12 B Purchase Satter Muneer A Large shareholder
10,000 +0.1%
3.06
US$30,615 		10,000 +0.1% 3.06 US$30,615
2017-06-13 2017-06-09 B Purchase Ashley Robert A.

Chief Technical Officer, EVP
2,000 +inf%
3.18
US$6,360 		2,000 +inf% 3.18 US$6,360
2017-06-12 2017-06-09 B Purchase Satter Muneer A Large shareholder
10,000 +0.1%
3.17
US$31,733 		10,000 +0.1% 3.17 US$31,733
2017-06-12 2017-06-08 B Purchase Satter Muneer A Large shareholder
10,000 +0.1%
3.10
US$30,958 		10,000 +0.1% 3.10 US$30,958
2017-06-09 2017-06-08 B Purchase Nash Duane

President
3,900 +90.2%
3.12
US$12,182 		3,900 +90.2% 3.12 US$12,182
2017-06-07 2017-06-07 B Purchase Satter Muneer A Large shareholder
10,000 +0.1%
3.21
US$32,074 		10,000 +0.1% 3.21 US$32,074
2017-06-07 2017-06-06 B Purchase Satter Muneer A Large shareholder
10,000 +0.1%
3.19
US$31,940 		10,000 +0.1% 3.19 US$31,940
2017-03-27 2017-03-27 B Purchase Satter Muneer A Large shareholder
3,750,000 +52.6%
4.00
US$15,000,000 		3,750,000 +52.6% 4.00 US$15,000,000
2016-08-15 2016-08-12 B Purchase
2.7
Hasnain Faheem
Non-Executive Director
118,243 +2627.6%
5.92
US$699,999 		118,243 +2627.6% 5.92 US$699,999
2015-10-29 2015-10-28 B Purchase Satter Muneer A Non-Executive Director Large shareholder
400,000 +5.9%
5.50
US$2,200,000 		400,000 +5.9% 5.50 US$2,200,000
2015-10-27 2015-10-26 B Purchase DUNN JOHN MICHAEL

General Counsel and Secretary

Officer
2,000 +27.1%
7.00
US$14,000 		2,000 +27.1% 7.00 US$14,000
2015-10-27 2015-10-26 B Purchase Cohen Cheryl Non-Executive Director
3,500 +inf%
7.17
US$25,090 		3,500 +inf% 7.17 US$25,090
2015-10-27 2015-10-23 B Purchase DUNN JOHN MICHAEL

General Counsel and Secretary

Officer
7,385 +inf%
6.76
US$49,933 		7,385 +inf% 6.76 US$49,933
2015-09-11 2015-09-10 B Purchase BIENAIME JEAN JACQUES Non-Executive Director
6,000 +18.1%
3.05
US$18,293 		6,000 +18.1% 3.05 US$18,293
2015-09-11 2015-09-09 B Purchase
2.4
BIENAIME JEAN JACQUES
Non-Executive Director
2,000 +6.4%
3.16
US$6,320 		2,000 +6.4% 3.16 US$6,320
2015-09-11 2015-09-09 B Purchase
2.4
BIENAIME JEAN JACQUES
Non-Executive Director
2,000 +6.9%
3.10
US$6,200 		2,000 +6.9% 3.10 US$6,200
2015-09-11 2015-09-09 B Purchase
2.4
BIENAIME JEAN JACQUES
Non-Executive Director
4,000 +15.9%
3.07
US$12,280 		4,000 +15.9% 3.07 US$12,280
2014-10-14 2014-10-10 B Purchase Winters Terence E.

Co-Chairman and CEO

Executive Director
680 +0.4%
14.90
US$10,132 		680 +0.4% 14.90 US$10,132
Explore more

More insider trading research around Immunic Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America